“ADVANTAGES OF USING LIPOSOME-ENCAPSULATED ANTIBIOTICS TO FIGHT INFECTIONS CAUSED BY ENTEROBACTERIA” (2024) Journal of Population Therapeutics and Clinical Pharmacology, 31(9), pp. 731–740. doi:10.53555/nhwgvd87.